Safety, tolerability and pharmacokinetics (PK) of AZD8154 (a selective PI3K?d inhibitor) after single ascending inhaled doses in healthy volunteers

M. Sadiq (Gothenburg, Sweden), S. Asimus (Gothenburg, Sweden), C. Kristensson (Gothenburg, Sweden), A. Hagberg (Gothenburg, Sweden), J. Mäenpää (Gothenburg, Sweden), B. Valastro (Gothenburg, Sweden), R. Fuhr (Berlin, Germany), T. Koernicke (Berlin, Germany), C. Keen (Gothenburg, Sweden), W. Brailsford (Gothenburg, Sweden), J. Betts (Gothenburg, Sweden)

Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets
Session: Airway inflammation: pharmacological mechanisms and novel targets
Session type: Thematic Poster
Number: 4220

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Sadiq (Gothenburg, Sweden), S. Asimus (Gothenburg, Sweden), C. Kristensson (Gothenburg, Sweden), A. Hagberg (Gothenburg, Sweden), J. Mäenpää (Gothenburg, Sweden), B. Valastro (Gothenburg, Sweden), R. Fuhr (Berlin, Germany), T. Koernicke (Berlin, Germany), C. Keen (Gothenburg, Sweden), W. Brailsford (Gothenburg, Sweden), J. Betts (Gothenburg, Sweden). Safety, tolerability and pharmacokinetics (PK) of AZD8154 (a selective PI3K?d inhibitor) after single ascending inhaled doses in healthy volunteers. 4220

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: